PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532796
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532796
Cardiopulmonary Bypass Equipment Market size was valued at USD 440.90 Million in 2023, expanding at a CAGR of 9.10% from 2024 to 2032.
Cardiopulmonary bypass (CPB) equipment is a specialized machinery used during cardiac surgery to temporarily take over the functions of the heart and lungs. This equipment is crucial because it allows surgeons to operate on a still and bloodless heart, facilitating complex procedures that would otherwise be impossible.
Cardiopulmonary Bypass Equipment Market- Market Dynamics
The growing prevalence of cardiovascular disorders and increasing technological advancement are expected to propel market demand
The rise in the incidence of cardiovascular diseases such as coronary artery disease, congenital heart defects, and valvular heart disease continues to increase globally, the demand for cardiac surgeries that utilize CPB equipment also rises, which is boosting the market growth. This demographic trend drives the market as more patients require surgical interventions to treat complex heart conditions. Moreover, investments in healthcare infrastructure in emerging markets like China, India, coupled with increasing access to healthcare services, contribute to the expansion of the CPB equipment market.
Furthermore, continuous innovations in CPB equipment technology aim to improve safety, efficiency, and outcomes for patients undergoing cardiac surgery. Advances include better materials for oxygenators and tubing, enhanced monitoring capabilities, improvements in pump technology, and innovations in anticoagulation management systems. These advancements attract healthcare providers seeking state-of-the-art equipment that can enhance surgical precision and patient recovery. Besides these, stringent regulatory requirements and guidelines regarding patient safety and surgical outcomes drive healthcare providers to adopt CPB equipment that meets regulatory standards.
Cardiopulmonary Bypass Equipment Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.10% over the forecast period (2024-2032)
Based on Product segmentation, the heart-lung machines segment was predicted to show maximum market share in the year 2023, owing to the high demand for pulmonary disease needs.
Based on Application segmentation, the cardiovascular segment was the leading Application in 2023, due to the high number of patients suffering from at least cardiovascular disease.
Based on End User segmentation, the hospital & clinics segment was the leading End User in 2023, owing to increased development across clinics & hospital facilities.
On the basis of region, North America was the leading revenue generator in 2023, owing to developed healthcare infrastructure.
The Global Cardiopulmonary Bypass Equipment Market is segmented on the basis of Product, Application, End User, and Region.
The market is divided into four categories based on Product: heart-lung machines, oxygenators, autotransfusion systems, and others. The heart-lung machines segment dominates the market. The high prevalence of lung & heart-related ailments is expanding segment growth.
The market is divided into four categories based on Application: cardiovascular, respiratory, hemodialysis, and others. The cardiovascular segment dominates the market. The rising prevalence of cardiac ailments and other pulmonary diseases is stimulating market growth.
The market is divided into four categories based on End Users: hospitals & clinics, ambulatory surgical centers, dialysis centers, and others. The hospitals & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The rising prevalence of cardiological disorders among older adults is mainly boosting segment growth.
Cardiopulmonary Bypass Equipment Market- Geographical Insights
Globally, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant share of the global CPB equipment market, driven by advanced healthcare infrastructure, high healthcare expenditure, and a large patient pool requiring cardiac surgeries. Latin America is experiencing steady growth in the CPB equipment market, driven by improving healthcare infrastructure. Supportive efforts to expand access to healthcare services and improve surgical capabilities in countries like Brazil and Mexico contribute to market growth.
The market for cardiopulmonary bypass equipment is influenced by technological innovation, market expansion strategies, regulatory compliance, and a focus on enhancing surgical outcomes and patient safety. Companies differentiate themselves through product innovation, global market presence, customer support, and strategic partnerships to expand their reach. Some companies focus on offering cost-effective solutions without compromising on quality, catering to healthcare providers in emerging markets and budget-conscious settings. For example, Terumo offers comprehensive customer support and training programs for healthcare professionals, enhancing product adoption and customer satisfaction.
In March 2023, LivaNova received the US Food and Drug Administration (FDA) clearance for Essenz heart-lung machine (HLM) for use in cardiopulmonary bypass (CPB) treatment.
In August 2022, Abiomed's Impella ECP expandable percutaneous heart pump was awarded with breakthrough privileges from the FDA.